4//SEC Filing
Goeltz II Robert C. 4
Accession 0001724521-24-000180
CIK 0001724521other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 8:36 PM ET
Size
4.8 KB
Accession
0001724521-24-000180
Insider Transaction Report
Form 4
Goeltz II Robert C.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-12-15$16.08/sh−10,099$162,392→ 63,732 total
Footnotes (1)
- [F1]Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001653881
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 8:36 PM ET
- Size
- 4.8 KB